Assignee
YUHAN CORP
KR·81 granted patents·23 pending applications·339 citations·filing 1989–2025
Top patents by PatentIndex Score
104 records- 0195US11492335B2Aryl or heteroaryl triazolone derivatives or salts thereof, or pharmaceutical compositions comprising the sameYUHAN CORP·Filed 2020·Granted Nov 8, 2022·5 cites·17 claims
- 0295US11286253B2Process for preparing aminopyrimidine derivativesYUHAN CORP·Filed 2020·Granted Mar 29, 2022·4 cites·10 claims
- 0395US10562865B2Aryl or heteroaryl triazolone derivatives or salts thereof, or pharmaceutical compositions comprising the sameYUHAN CORP·Filed 2019·Granted Feb 18, 2020·11 cites·29 claims
- 0494US10899719B2Aryl or heteroaryl triazolone derivatives or salts thereof, or pharmaceutical compositions comprising the sameYUHAN CORP·Filed 2019·Granted Jan 26, 2021·8 cites·9 claims
- 0593US9593098B2Compounds and compositions for modulating EGFR mutant kinase activitiesYUHAN CORP·Filed 2015·Granted Mar 14, 2017·19 cites·20 claims
- 0692US11713308B23,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the sameYUHAN CORP·Filed 2021·Granted Aug 1, 2023·2 cites·9 claims
- 0792US11091479B2Triazolopyridin-3-ones or their salts and pharmaceutical compositions comprising the sameYUHAN CORP·Filed 2019·Granted Aug 17, 2021·6 cites·38 claims
- 0892US10995086B2Triazolone derivatives or salts thereof and pharmaceutical compositions comprising the sameYUHAN CORP·Filed 2019·Granted May 4, 2021·7 cites·30 claims
- 0991US11168073B23,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the sameYUHAN CORP·Filed 2019·Granted Nov 9, 2021·5 cites·32 claims
- 1091US11136364B2Dual function proteins comprising FGF21 mutant protein and pharmaceutical composition comprising sameYUHAN CORP·Filed 2016·Granted Oct 5, 2021·6 cites·25 claims
- 1191US10889578B2Process for preparing aminopyrimidine derivativesYUHAN CORP·Filed 2018·Granted Jan 12, 2021·4 cites·33 claims
- 1290USD965984SToothbrushYUHAN CORP·Filed 2020·Granted Oct 11, 2022·14 cites·1 claims
- 1388US6680053B2Variable region of the monoclonal antibody against the HBV S-surface antigen and a gene encoding the sameYUHAN CORP·Filed 2001·Granted Jan 20, 2004·19 cites·3 claims
- 1487US12428401B2Salt of an aminopyridine derivative compound, a crystalline form thereof, and a process for preparing the sameYUHAN CORP·Filed 2024·Granted Sep 30, 2025·0 cites·8 claims
- 1587US5750531APyrimidine derivatives and processes for the preparation thereofYUHAN CORP·Filed 1995·Granted May 12, 1998·91 cites·13 claims
- 1685US12187714B2Process for preparing aminopyrimidine derivativesYUHAN CORP·Filed 2023·Granted Jan 7, 2025·0 cites·3 claims
- 1785US6252076B1Process for preparation of pyrimidine derivativesYUHAN CORP·Filed 2000·Granted Jun 26, 2001·18 cites·2 claims
- 1885US2024190959A1Antigen Binding Proteins that Bind PD-L1YUHAN CORP·Filed 2024·Application pending·0 cites
- 1981US8367704B2Process for preparation of 2-methyl-2′ phenylpropionic acid derivatives and novel intermediate compoundsYUHAN CORP·Filed 2009·Granted Feb 5, 2013·3 cites·12 claims
- 2081US2024417392A13,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the sameYUHAN CORP·Filed 2024·Application pending·0 cites
- 2180US12522602B2Derivatives having 2,3-dihydro-1H-indene or 2,3-dihydrobenzofuran moiety or pharmaceutically acceptable salt thereof and pharmaceutical compositions comprising the sameYUHAN CORP·Filed 2020·Granted Jan 13, 2026·1 cites·28 claims
- 2280US7662832B2Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereofYUHAN CORP·Filed 2005·Granted Feb 16, 2010·6 cites·6 claims
- 2380US7196177B2Antibody variable region of a monoclonal antibody against human tumor necrosis factor alpha and a gene encoding the sameYUHAN CORP·Filed 2006·Granted Mar 27, 2007·4 cites·5 claims
- 2479US10227330B2Diaminopyrimidine derivatives and processes for the preparation thereofYUHAN CORP·Filed 2017·Granted Mar 12, 2019·2 cites·6 claims
- 2579US2025270269A1Dual function proteins comprising fgf21 mutant protein and pharmaceutical composition comprising sameYUHAN CORP·Filed 2024·Application pending·0 cites
- 2678US11708362B2Process for preparing aminopyrimidine derivativesYUHAN CORP·Filed 2022·Granted Jul 25, 2023·0 cites·1 claims
- 2777US7645450B2Humanized antibody specific for tumor necrosis factor-alphaYUHAN CORP·Filed 2005·Granted Jan 12, 2010·4 cites·6 claims
- 2876US11919952B2Antigen binding proteins that bind PD-L1YUHAN CORP·Filed 2021·Granted Mar 5, 2024·0 cites·19 claims
- 2976US6924368B2Variable region of the monoclonal antibody against the HBV S-surface antigen and a gene encoding the sameYUHAN CORP·Filed 2003·Granted Aug 2, 2005·3 cites·7 claims
- 3076US2024279296A1Long-acting fgf21 fusion proteins and pharmaceutical composition comprising sameYUHAN CORP·Filed 2023·Application pending·0 cites
- 3175US12338237B2Derivatives having 1,2,3,4-tetrahydronaphthalene moiety or pharmaceutically acceptable salt thereof and pharmaceutical compositions comprising the sameYUHAN CORP·Filed 2020·Granted Jun 24, 2025·1 cites·18 claims
- 3275US2023212249A1Method for producing dual function proteins and its derivativesYUHAN CORP·Filed 2022·Application pending·0 cites
- 3374US7112664B2Variable region of the monoclonal antibody against the HBV S-surface antigen and a gene encoding the sameYUHAN CORP·Filed 2003·Granted Sep 26, 2006·2 cites·5 claims
- 3473US11945798B2Substituted aminopyridine compounds as EGFR inhibitorsYUHAN CORP·Filed 2022·Granted Apr 2, 2024·0 cites·39 claims
- 3573US6251427B1Pharmaceutical capsule compositions containing loratadine and psuedoephedrineYUHAN CORP·Filed 2000·Granted Jun 26, 2001·11 cites·3 claims
- 3673US2026035429A1Method for producing dual function proteins and its derivativesYUHAN CORP·Filed 2025·Application pending·0 cites
- 3772USRE50528ECompounds and compositions for modulating EGFR mutant kinase activitiesYUHAN CORP·Filed 2022·Granted Aug 12, 2025·0 cites·23 claims
- 3872US12258328B26-membered heteroaryl-containing aminopyridine compounds as EGFR inhibitorsYUHAN CORP·Filed 2022·Granted Mar 25, 2025·0 cites·20 claims
- 3972US7109320B2Nucleic acid molecules encoding human tumor necrosis factor α-specific antibodiesYUHAN CORP·Filed 2004·Granted Sep 19, 2006·2 cites·10 claims
- 4072US2026098038A1Novel derivatives having 2,3-dihydro-1h-indene or 2,3-dihydrobenzofuran moiety or pharmaceutically acceptable salt thereof and pharmaceutical compositions comprising the sameYUHAN CORP·Filed 2025·Application pending·0 cites
- 4171US12258327B25-membered heteroaryl-containing aminopyridine compounds as EGFR inhibitorsYUHAN CORP·Filed 2022·Granted Mar 25, 2025·0 cites·25 claims
- 4271US11981659B2Salt of an aminopyridine derivative compound, a crystalline form thereof, and a process for preparing the sameYUHAN CORP·Filed 2022·Granted May 14, 2024·0 cites·17 claims
- 4370US11623925B2Processes for preparing a diaminopyrimidine derivative or acid addition salt thereofYUHAN CORP·Filed 2022·Granted Apr 11, 2023·0 cites·6 claims
- 4470US5739105ACyclosporin containing composition and process for the preparation thereofYUHAN CORP·Filed 1995·Granted Apr 14, 1998·38 cites·11 claims
- 4569US11820769B2Triazolopyridin-3-ones or their salts and pharmaceutical compositions comprising the sameYUHAN CORP·Filed 2021·Granted Nov 21, 2023·0 cites·26 claims
- 4669US7342027B21-phenylpiperidin-3-one derivatives and processes for the preparation thereofYUHAN CORP·Filed 2003·Granted Mar 11, 2008·6 cites·10 claims
- 4768US7541366B2Pyrrolo[3,2-c]pyridine derivatives and processes for the preparation thereofYUHAN CORP·Filed 2005·Granted Jun 2, 2009·1 cites·7 claims
- 4868US2022002367A1Long-acting fgf21 fusion proteins and pharmaceutical composition comprising sameYUHAN CORP·Filed 2021·Application pending·0 cites
- 4968US2022002368A1Dual function proteins comprising fgf21 mutant protein and pharmaceutical composition comprising sameYUHAN CORP·Filed 2021·Application pending·0 cites
- 5067USD965985SToothbrushYUHAN CORP·Filed 2020·Granted Oct 11, 2022·3 cites·1 claims
Showing the top 50 of 104 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →